- Home
- MRVI vs CFFN Comparison
MRVI vs CFFN Comparison
Compare MRVI & CFFN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MRVI | CFFN |
|---|---|---|
| Founded | 2014 | 1893 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Savings Institutions |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 902.7M | 981.1M |
| IPO Year | 2020 | 2010 |
Fundamental Metrics
Financial Performance| Metric | MRVI | CFFN |
|---|---|---|
| Price | $6.39 | $8.46 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 4 | 2 |
| Target Price | $4.13 | ★ $7.25 |
| AVG Volume (30 Days) | ★ 3.3M | 799.0K |
| Earning Date | 05-07-2026 | 04-29-2026 |
| Dividend Yield | N/A | ★ 4.51% |
| EPS Growth | 14.29 | ★ 79.31 |
| EPS | N/A | ★ 0.32 |
| Revenue | ★ $185,743,000.00 | $16,300,000.00 |
| Revenue This Year | $12.54 | $20.16 |
| Revenue Next Year | $7.87 | $6.62 |
| P/E Ratio | ★ N/A | $26.50 |
| Revenue Growth | N/A | ★ 6.54 |
| 52 Week Low | $1.99 | $5.71 |
| 52 Week High | $6.29 | $8.58 |
Technical Indicators
Market Signals| Indicator | MRVI | CFFN |
|---|---|---|
| Relative Strength Index (RSI) | 84.41 | 68.73 |
| Support Level | $3.27 | $7.49 |
| Resistance Level | N/A | N/A |
| Average True Range (ATR) | 0.31 | 0.16 |
| MACD | 0.10 | 0.04 |
| Stochastic Oscillator | 89.40 | 83.59 |
Price Performance
Historical ComparisonAbout MRVI Maravai LifeSciences Holdings Inc.
Maravai LifeSciences Holdings Inc is a life sciences company providing products and services to enable the development of drugs, therapeutics, vaccines and diagnostics, and to support research on human disease. Its product portfolio includes complex nucleic acids, custom enzymes and antibody-based solutions for therapeutic, vaccine, diagnostic and biopharmaceutical production applications. The Company operates through two segments: TriLink, which generates maximum revenue from North America and provides nucleic acid products and services including mRNA, oligonucleotides and related technologies; and Cygnus, which provides biologics safety testing products and services including host cell protein ELISA kits, impurity detection assays and related reagents and services.
About CFFN Capitol Federal Financial Inc.
Capitol Federal Financial Inc is a bank holding company that operates through its wholly-owned subsidiary bank. The bank is a community-oriented financial institution that offers a variety of financial services through tens of locations. It mainly serves metropolitan areas within the state of Kansas. The bank performs traditional banking functions such as deposit-taking activities and investing that money in first-lien residential mortgages. It also participates in commercial real estate loans with other lenders, investing those funds in various securities. The vast majority of the bank's loan portfolio is in originated one- to four-family real estate loans. Its primary source of income is net interest income.